Yahong Chen

7.0k total citations · 1 hit paper
188 papers, 2.8k citations indexed

About

Yahong Chen is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Yahong Chen has authored 188 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 30 papers in Physiology and 26 papers in Epidemiology. Recurrent topics in Yahong Chen's work include Chronic Obstructive Pulmonary Disease (COPD) Research (72 papers), Air Quality and Health Impacts (22 papers) and Respiratory Support and Mechanisms (21 papers). Yahong Chen is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (72 papers), Air Quality and Health Impacts (22 papers) and Respiratory Support and Mechanisms (21 papers). Yahong Chen collaborates with scholars based in China, United States and Japan. Yahong Chen's co-authors include Zhiwei Zheng, Furong Deng, Wan-zhen Yao, Shaowei Wu, Xiansong Wang, Xinbiao Guo, Shao-wei Li, Xin‐Li Mao, Lü Pan and Hongyu Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Yahong Chen

177 papers receiving 2.8k citations

Hit Papers

Reactive Oxygen Species Induce Fatty Liver and Ischemia-R... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yahong Chen China 28 836 609 493 317 310 188 2.8k
Laura S. Van Winkle United States 35 1.3k 1.5× 1.3k 2.1× 825 1.7× 684 2.2× 363 1.2× 110 4.3k
Zu‐Yao Yang China 33 1.0k 1.2× 570 0.9× 534 1.1× 233 0.7× 58 0.2× 95 3.6k
Shengfeng Wang China 26 223 0.3× 303 0.5× 522 1.1× 234 0.7× 225 0.7× 171 3.2k
Xueli Yang China 29 221 0.3× 776 1.3× 616 1.2× 402 1.3× 106 0.3× 190 3.8k
Thomas Schulz Germany 34 296 0.4× 614 1.0× 555 1.1× 452 1.4× 231 0.7× 110 4.4k
Michiel Thomeer Belgium 25 2.7k 3.3× 921 1.5× 511 1.0× 1.1k 3.4× 176 0.6× 75 4.6k
Cédric Hermans Belgium 39 1.1k 1.3× 523 0.9× 868 1.8× 337 1.1× 144 0.5× 281 6.0k
Liying Wang China 35 870 1.0× 124 0.2× 872 1.8× 471 1.5× 283 0.9× 183 4.0k
Brian G. Miller United States 37 711 0.9× 1.1k 1.8× 1.3k 2.7× 387 1.2× 158 0.5× 131 3.7k
Christine E. McLaren United States 40 340 0.4× 261 0.4× 970 2.0× 321 1.0× 139 0.4× 129 5.9k

Countries citing papers authored by Yahong Chen

Since Specialization
Citations

This map shows the geographic impact of Yahong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yahong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yahong Chen more than expected).

Fields of papers citing papers by Yahong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yahong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yahong Chen. The network helps show where Yahong Chen may publish in the future.

Co-authorship network of co-authors of Yahong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yahong Chen. A scholar is included among the top collaborators of Yahong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yahong Chen. Yahong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Jiaming, et al.. (2026). Dynamic FIB-4 trajectory and a multi-state Markov model analysis reveal fibrosis progression and cardiovascular-cerebrovascular risk in MAFLD patients. Nutrition Metabolism and Cardiovascular Diseases. 104617–104617.
2.
Li, Wei, et al.. (2025). Multimorbidity Patterns of Asthma Exacerbation in an Older Cohort: Prognostic Implications. The Journal of Allergy and Clinical Immunology In Practice. 13(7). 1793–1806.e2. 1 indexed citations
4.
Wang, Ruiying, et al.. (2024). Exosome microRNA-125a-5p derived from epithelium promotes M1 macrophage polarization by targeting IL1RN in chronic obstructive pulmonary disease. International Immunopharmacology. 137. 112466–112466. 12 indexed citations
5.
Shen, Jienan, Yahong Chen, Lin Yang, et al.. (2024). DNA-AuNP encoders array Integrating a multi-modal coupled analysis approach for noninvasive precision screening of myocardial function injury disease in children. Chemical Engineering Journal. 490. 151890–151890. 1 indexed citations
6.
Huang, Ke, Xueyan Han, Jianping Zhao, et al.. (2024). Impact of Using Pre- and Postbronchodilator Spirometry Reference Values in a Chinese Population. American Journal of Respiratory and Critical Care Medicine. 210(7). 881–889. 1 indexed citations
8.
Zhang, Wenlou, Junyi Wang, Zhao Chen, et al.. (2023). Association of multiple air pollutants with oxygen saturation during sleep in COPD patients: Effect modification by smoking status and airway inflammatory phenotypes. Journal of Hazardous Materials. 454. 131550–131550. 14 indexed citations
9.
Yang, Ting, Baiqiang Cai, Bin Cao, et al.. (2023). REALizing and improving management of stable COPD in China: results of a multicentre, prospective, observational study (REAL). Therapeutic Advances in Respiratory Disease. 17. 2683758020–2683758020. 5 indexed citations
10.
Yang, Ting, Baiqiang Cai, Bin Cao, et al.. (2023). Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL). Therapeutic Advances in Respiratory Disease. 17. 2683746681–2683746681. 5 indexed citations
11.
Wu, Hongwei, et al.. (2023). The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis. Stem Cells International. 2023. 1–11. 9 indexed citations
13.
Fan, Jing, Liwen Fang, Shu Cong, et al.. (2023). Potential pre-COPD indicators in association with COPD development and COPD prediction models in Chinese: a prospective cohort study. The Lancet Regional Health - Western Pacific. 44. 100984–100984. 11 indexed citations
14.
Chen, Yahong, et al.. (2022). Association of Helicobacter pylori infection with osteoporosis risk in a physical examination population. Archives of Osteoporosis. 17(1). 35–35. 3 indexed citations
15.
Huang, Ke, Kewu Huang, Jianying Xu, et al.. (2021). Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease in China: Results from the China Pulmonary Health [CPH] Study. SHILAP Revista de lepidopterología. 15 indexed citations
16.
Chen, Hongyi, Zhicheng Zhang, Zhihua Huang, et al.. (2020). First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients. Medicine. 99(48). e23357–e23357. 79 indexed citations
17.
Chen, Yahong, Yang Liu, Wan-zhen Yao, et al.. (2020). <p>Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis</p>. International Journal of COPD. Volume 15. 2343–2353. 5 indexed citations
18.
Chen, Yahong, Chun‐Chin Chang, Jian Kang, et al.. (2015). [Present status of medical treatment for patients with chronic obstructive pulmonary disease based upon different severity classifications].. PubMed. 95(8). 570–6. 1 indexed citations
19.
Chen, Yahong, et al.. (2008). Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease. Chinese Medical Journal. 121(7). 587–591. 32 indexed citations
20.
Chen, Yahong, et al.. (2005). [Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease].. PubMed. 28(10). 694–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026